Journal of Korean Medical Science · 2011 · 41 citations · 20 references
Life SciencesGeneticsMolecular GeneticsCancer GeneticsDna RepairHuman GeneticsEndocrine Tumor GeneticsGenetic Risk AssessmentGermline Cancer PredispositionMolecular MarkersThyroid CancerAmplified Fragment Length Polymorphism MarkersCancer Risk AssociationExcision Repair Cross-complementation Group 1Molecular Biomarker ScreeningRiskSingle-nucleotide Polymorphism Risk AnalysisThyroid Cancer GeneticsThyroid Cancer Risk
Polymorphisms of DNA repair genes, X-ray repair cross-complementing group 1 (XRCC1) might contribute to individual susceptibility to different types of cancers. We analyzed the relationship between XRCC1 polymorphisms and the risk of papillary thyroid carcinoma in a Korean sample. A hospital-based case-control study was performed in 111 papillary thyroid carcinoma patients and 100 normal control subjects. XRCC1 Arg194Trp and Arg399Gln single nucleotide polymorphisms (SNPs) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). The XRCC1 Arg194Trp Arg/Trp genotype was significantly associated with a decreased risk of papillary thyroid carcinoma compared to that of Arg/Arg genotype (odds ratio [95% confidence intervals]; 0.550 [0.308-0.983]). There was no significant association between XRCC1 Arg399Gln genotypes and risk of papillary thyroid carcinoma. Based on these results, the XRCC1 Arg194Trp Arg/Trp genotype could be used as a useful molecular biomarker to predict genetic susceptibility for papillary thyroid carcinoma in Koreans.
20
Cancer Statistics in Korea: Incidence, Mortality and Survival in 2006-2007
Kyu‐Won Jung, Sohee Park, Hyun-Joo Kong et al. · Journal of Korean Medical Science · 2010 · 297 citations · Full text
Structure of an XRCC1 BRCT domain: a new protein–protein interaction module
Xiaodong Zhang, S. Moréra, Paul A. Bates et al. · The EMBO Journal · 1998 · 253 citations